HomeOwner SearchCategory Search
Visit USCOCytokine-gene-engineered tumor vaccines for the treatment of spontaneous canine melanoma
Text Registration
Copyright Title
Cytokine-gene-engineered tumor vaccines for the treatment of spontaneous canine melanoma
Status
Published
on 14 Jun 2007
Year of Creation
1999
Copyright Claimant
Gary S. Hogge
Registration Number
TX0005163122
on 14 Jun 2007Copyright Summary
The U.S. Copyright record (Registration Number: TX0005163122) dated 14 Jun 2007, pertains to an electronic file (eService) titled "Cytokine-gene-engineered tumor vaccines for the treatment of spontaneous canine melanoma" created in 1999. The copyright holder is Gary S. Hogge, known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to Gary S. Hogge.
Application Details
Registration Number
TX0005163122
Registration Date
6/14/2007
Year of Creation
1999
Agency Marc Code
DLC-CO
Record Status
New
Physical Description
Computer text data
Notes
Rights Note: Rights and permissions info. on CORDS appl. in CO
Local Copyright Note: C.O. correspondence
Bibliographic Note: Electronic registration
Statements
Author Statement: entire text: Gary S. Hogge
© 2024 reserved by Trademarkia
Show terms & conditions
Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.